Pharma
Webinar: Integrated prediction of phase I and II metabolism
Want to avoid late-stage failure of your drug candidates? Understanding the metabolism of your compounds is crucial. On 24 May, join Optibrium CEO Matt Segall and Principal Scientist Mario Öeren to explore groundbreaking new quantum mechanics and machine learning models which...
US patent granted protecting proprietary formulations of monoclonal antibodies
Endorses potential of proprietary Arestat™ platform technology to invent novel, enhanced therapeutics in $210 billion monoclonal antibody market Further strengthens Group’s extensive patent portfolio Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical group advancing today’...
Guardtech Group raising the bar with new Cleanroom Solutions website
Haverhill cleanroom construction company elevate their turnkey offering with launch of ground-breaking new website ...
Breaking into Healthcare Markets
Everything medtech and healthtech innovators need to know about breaking into the NHS or key export markets. ...
New Approaches to Facilitate Drug Discovery
Join Medicilon at 2023 Annual UK Symposium: New Approaches to Facilitate Drug Discovery New approaches applied to drug discovery by the medical community and pharmaceutical industry have a direct impact on the development of improved, novel, and curative therapies for patients. Medicil...
Maxion Therapeutics awarded £2 million Innovate UK funding to develop ion channel antibodies for “hard-to-treat" autoimmune diseases
Biotechnology company Maxion Therapeutics announces it has been awarded a prestigious GBP £2 million grant from Innovate UK, as part of its Biomedical Catalyst 2022 Round 2: Industry-led R&D funding competition. ...
Cresset April 2023 Newsletter
Explore some advanced computational chemistry methods such as FEP and Python workflows, alongside a range of exciting news in the Cresset April newsletter! ...
Cambridge winners in Microbiology Society awards
Two Addenbrooke’s experts who led the fight against COVID-19 are to be presented with prestigious awards at a major national conference this week. ...
CCDC Webinar: Boosting Research Efficiency in Industry with FAIR Data
The ability to leverage existing data, whether public or proprietary, strengthens chemistry research. ...
Cambridge Innovation Capital invests in Complement Therapeutics’ €72 Million Series A Funding
Cambridge Innovation Capital (CIC), the venture capital investor focused on deeptech and life sciences businesses in the Cambridge ecosystem, has invested in Complement Therapeutics’ €72 Million Series A funding round led by Gimv and co-led by Forbion, alongside existing investor B...